Basic Materials / Specialty ChemicalsNYSE
$52.93
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $25.4M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
25/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.2B
P/E
N/A
•EV/EBITDA
N/A
•ROE
3.8%
↑Gross Margin
11.6%
↓Debt/Equity
0.27
↑Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
+3.8%
FCF CAGR
-9.4%
FCF margin
1.1%
FCF / Net income
0.54x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.33B · net income $46.9M · FCF $25.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $2.33B | $2.33B | $2.18B | $2.33B | $2.77B | $2.35B | $1.87B | $1.86B | $1.99B | $1.93B | $1.77B | $1.78B | $1.93B | $1.88B | $1.80B | $1.84B | $1.43B | $1.28B |
| Net Income | $46.9M | $46.9M | $50.4M | $40.2M | $147.2M | $137.8M | $126.8M | $103.1M | $111.1M | $100.8M | $86.2M | $76.0M | $57.1M | $72.8M | $79.4M | $72.0M | $65.4M | $63.0M |
| EBITDA | $204.6M | $204.6M | $182.7M | $164.0M | $302.0M | $261.7M | $253.4M | $206.0M | $230.4M | $233.9M | $202.8M | $189.8M | $154.5M | $165.6M | $180.0M | $165.6M | $148.2M | $142.1M |
| EPS | 2.05 | 2.05 | 2.20 | 1.75 | 6.38 | 5.92 | 5.45 | 4.42 | 4.76 | 4.31 | 3.73 | 3.32 | 2.49 | 3.18 | 3.49 | 3.21 | 2.95 | 5.84 |
| Gross Margin | 11.6% | 11.6% | 12.5% | 11.9% | 15.4% | 16.9% | 20.5% | 18.3% | 17.0% | 18.0% | 19.2% | 17.4% | 12.9% | 15.0% | 16.2% | 13.9% | 16.5% | 18.3% |
| Operating Margin | 3.4% | 3.4% | 3.2% | 2.5% | 7.5% | 7.3% | 9.2% | 6.8% | 7.5% | 8.0% | 7.2% | 6.9% | 4.7% | 5.8% | 7.1% | 6.4% | 7.5% | 8.2% |
| Net Margin | 2.0% | 2.0% | 2.3% | 1.7% | 5.3% | 5.9% | 6.8% | 5.5% | 5.6% | 5.2% | 4.9% | 4.3% | 3.0% | 3.9% | 4.4% | 3.9% | 4.6% | 4.9% |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 0.27 | 0.27 | 0.28 | 0.33 | 0.39 | 0.30 | 0.16 | 0.22 | 0.30 | 0.36 | 0.46 | 0.56 | 0.46 | 0.43 | 0.31 | 0.41 | 0.46 | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $25.4M | $25.4M | $39.3M | $-85.5M | $-140.8M | $-122.3M | $109.4M | $112.9M | $84.5M | $120.3M | $109.1M | — | — | $57.4M | $25.8M | $-5.8M | $-7.6M | $123.8M |
| Returns | ||||||||||||||||||
| ROE | 3.8% | 3.8% | 4.3% | 3.3% | 12.6% | 12.8% | 12.8% | 11.6% | 13.8% | 13.6% | 13.6% | 13.6% | 10.7% | 13.2% | 16.6% | 17.9% | 18.7% | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | 7.0% | 7.0% | -6.3% | -16.1% | 18.2% | 25.5% | 0.6% | -6.8% | 3.6% | 9.0% | -0.6% | -7.8% | 2.5% | 4.3% | -2.1% | 28.8% | 12.1% | — |
| EPS Growth | -6.8% | -6.8% | 25.7% | -72.6% | 7.8% | 8.6% | 23.3% | -7.1% | 10.4% | 15.5% | 12.3% | 33.3% | -21.7% | -8.9% | 8.7% | 8.8% | -49.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
31.8%
EPS terminal req.
$4.70
Spread vs growth
-38.6%
5Y implied EPS CAGR
22.6%
EPS terminal req.
$5.68
Spread vs growth
-29.4%
10Y implied EPS CAGR
16.1%
EPS terminal req.
$9.15
Spread vs growth
-23.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.